Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today ...

• Eat well. Follow a Mediterranean or MIND diet built around vegetables, berries, nuts, whole grains and fish, while limiting ...

Transurethral ultrasound ablation (TULSA) is a minimally invasive procedure used to treat prostate conditions, especially prostate cancer that has not spread beyond the prostate. TULSA uses ultrasound ...

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative ...

Profound Medical Corp. a annoncé de nouvelles données issues de l'essai contrôlé randomisé de phase IV (post-commercialisation) CAPTAIN, comparant la procédure TULSA à la prostatectomie radicale ...

– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month – TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical ...

Dr. Meng commented, “UT Southwestern has helped pioneer the TULSA Procedure for prostate cancer, having reached the 100 th procedure milestone back in 2022, well before the CPT Category 1 codes became ...

Profound also announced that it is launching an initiative to explore the potential of integrating PSMA PET molecular imaging technologies with the TULSA Procedure to support intention-to-treat ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative ...